Safety and tolerability of once-daily tiotropium Respimat ® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis

Tiotropium, a long-acting anticholinergic bronchodilator, has demonstrated efficacy and safety as add-on therapy to inhaled corticosteroids (ICS), with or without other maintenance therapies, in patients with symptomatic asthma.

Source: Respiratory Medicine CME - July 3, 2016 Category: Respiratory Medicine Authors: Ronald Dahl, Michael Engel, Daniel Dusser, David Halpin, Huib A.M. Kerstjens, Liliana Zaremba-Pechmann, Petra Moroni-Zentgraf, William W. Busse, Eric D. Bateman Source Type: research